Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Monday's After-Market Session

Author: Benzinga Insights | July 28, 2025 05:05pm

Gainers

  • Adaptimmune Therapeutics (NASDAQ:ADAP) shares rose 17.0% to $0.12 during Monday's after-market session. The company's market cap stands at $91.9 million.
  • Milestone Scientific (AMEX:MLSS) shares moved upwards by 13.54% to $0.55. The company's market cap stands at $46.3 million.
  • Adial Pharmaceuticals (NASDAQ:ADIL) stock rose 10.9% to $0.7. The market value of their outstanding shares is at $8.1 million.
  • PTC Therapeutics (NASDAQ:PTCT) stock moved upwards by 8.25% to $48.0. The company's market cap stands at $3.5 billion.
  • Aclarion (NASDAQ:ACON) stock increased by 6.88% to $8.38. The company's market cap stands at $4.3 million.
  • Maze Therapeutics (NASDAQ:MAZE) stock increased by 6.62% to $17.37. The company's market cap stands at $736.6 million.

Losers

  • 180 Life Sciences (NASDAQ:ATNF) shares decreased by 18.9% to $2.36 during Monday's after-market session. The company's market cap stands at $18.1 million. As per the press release, Q2 earnings came out 3 days ago.
  • Exelixis (NASDAQ:EXEL) shares decreased by 13.27% to $38.5. The market value of their outstanding shares is at $12.4 billion. As per the press release, Q2 earnings came out today.
  • Metsera (NASDAQ:MTSR) shares declined by 8.7% to $36.0. The market value of their outstanding shares is at $4.2 billion.
  • Neumora Therapeutics (NASDAQ:NMRA) stock declined by 6.61% to $2.12. The market value of their outstanding shares is at $380.1 million.
  • Eledon Pharmaceuticals (NASDAQ:ELDN) shares fell 6.2% to $3.03. The company's market cap stands at $216.7 million.
  • Universe Pharmaceuticals (NASDAQ:UPC) shares decreased by 5.8% to $4.0. The company's market cap stands at $58.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ACON ADAP ADIL ATNF ELDN EXEL MAZE MLSS MTSR NMRA PTCT UPC

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist